Companies / Agios Pharmaceuticals, Inc. / Activity
Activity — Agios Pharmaceuticals, Inc.
106 moves.
Top impactInsider · CEO movesInsider · biggest buysInsider · biggest sellsInstitution · biggest movesInstitution · new positions
| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Dec 30, 2025 | Milanova Tsveta Executive | Sell | Common stock | $79.4K | -3K -9.13% | 29,190 0.05% of shares | low |
| Mar 5, 2026 | Viswanadhan Krishnan Executive | Sell | Common stock | $82.3K | -3K -36.53% | 5,141 <0.01% of shares | low |
| Mar 2, 2026 | Goff Brian CEO | Sell | Common stock | $112.1K | -4K -2.55% | 147,733 0.25% of shares | medium |
| Mar 3, 2026 | Washburn Theodore James Jr. Executive | Sell | Common stock | $152.3K | -5K -85.86% | 868 <0.01% of shares | medium |
| Dec 30, 2025 | Goff Brian CEO | Sell | Common stock | $168.8K | -6K -4.17% | 143,103 0.24% of shares | medium |
| Mar 2, 2026 | Goff Brian CEO | Sell | Common stock | $171.4K | -6K -3.47% | 164,548 0.28% of shares | medium |
| Mar 2, 2026 | Goff Brian CEO | Sell | Common stock | $239.4K | -8K -4.99% | 157,466 0.26% of shares | medium |
| Dec 30, 2025 | Goff Brian CEO | Sell | Common stock | $337.9K | -12K -8.37% | 136,583 0.23% of shares | medium |
| Jun 18, 2026 | Foster-Cheek Kaye I Director | Grant | Stock options (right to buy) | — | +15K | 14,950 0.03% of shares | low |
| Jun 18, 2026 | Foster-Cheek Kaye I Director | Grant | Restricted stock units | — | +3K | 2,927 <0.01% of shares | low |
| Jun 18, 2026 | Foster-Cheek Kaye I Director | Exercise | Restricted stock units | — | -3K -100.00% | 0 0.00% of shares | low |
| Jun 18, 2026 | Capello Jeffrey D Director | Grant | Stock options (right to buy) | — | +15K | 14,950 0.03% of shares | low |
| Jun 18, 2026 | Capello Jeffrey D Director | Grant | Restricted stock units | — | +3K | 2,927 <0.01% of shares | low |
| Jun 18, 2026 | Capello Jeffrey D Director | Exercise | Restricted stock units | — | -3K -100.00% | 0 0.00% of shares | low |
| Jun 13, 2026 | Capello Jeffrey D Director | Exercise | Restricted stock units | — | -2K -100.00% | 0 0.00% of shares | low |
| Mar 2, 2026 | Jones Cecilia Executive | Exercise | Restricted stock units | — | -5K -33.33% | 10,607 0.02% of shares | low |
| Mar 2, 2026 | Jones Cecilia Executive | Exercise | Restricted stock units | — | -4K -33.33% | 8,000 0.01% of shares | low |
| Mar 2, 2026 | Jones Cecilia Executive | Exercise | Restricted stock units | — | -6K -50.00% | 5,667 <0.01% of shares | low |
| Mar 2, 2026 | Jones Cecilia Executive | Exercise | Restricted stock units | — | -2K -100.00% | 0 0.00% of shares | low |
| Mar 1, 2026 | Jones Cecilia Executive | Grant | Stock options (right to buy) | — | +52K | 52,000 0.09% of shares | low |
| Mar 1, 2026 | Jones Cecilia Executive | Grant | Restricted stock units | — | +14K | 14,000 0.02% of shares | low |
| Dec 30, 2025 | Jones Cecilia Executive | Exercise | Performance share units | — | -6K -100.00% | 0 0.00% of shares | low |
| Mar 2, 2026 | Goff Brian CEO | Exercise | Restricted stock units | — | -13K -33.33% | 26,000 0.04% of shares | low |
| Mar 2, 2026 | Goff Brian CEO | Exercise | Restricted stock units | — | -18K -50.00% | 18,000 0.03% of shares | low |
| Mar 2, 2026 | Goff Brian CEO | Exercise | Restricted stock units | — | -9K -100.00% | 0 0.00% of shares | low |
| Mar 1, 2026 | Goff Brian CEO | Grant | Stock options (right to buy) | — | +174K | 174,000 0.29% of shares | low |
| Mar 1, 2026 | Goff Brian CEO | Grant | Restricted stock units | — | +48K | 48,000 0.08% of shares | low |
| Dec 30, 2025 | Goff Brian CEO | Exercise | Performance share units | — | -13K -100.00% | 0 0.00% of shares | low |
| Dec 30, 2025 | Goff Brian CEO | Exercise | Performance share units | — | -26K -50.00% | 25,528 0.04% of shares | low |
| Mar 5, 2026 | Viswanadhan Krishnan Executive | Exercise | Restricted stock units | — | -8K -33.33% | 16,200 0.03% of shares | low |
| Mar 2, 2026 | Burns James William Executive | Exercise | Restricted stock units | — | -4K -33.34% | 7,839 0.01% of shares | low |
| Mar 2, 2026 | Burns James William Executive | Exercise | Restricted stock units | — | -4K -33.33% | 8,000 0.01% of shares | low |
| Mar 2, 2026 | Burns James William Executive | Exercise | Restricted stock units | — | -6K -50.00% | 5,667 <0.01% of shares | low |
| Mar 2, 2026 | Burns James William Executive | Exercise | Restricted stock units | — | -4K -100.00% | 0 0.00% of shares | low |
| Mar 1, 2026 | Burns James William Executive | Grant | Stock options (right to buy) | — | +52K | 52,000 0.09% of shares | low |
| Mar 1, 2026 | Burns James William Executive | Grant | Restricted stock units | — | +14K | 14,000 0.02% of shares | low |
| Mar 2, 2026 | Gheuens Sarah Executive | Exercise | Restricted stock units | — | -4K -33.33% | 8,000 0.01% of shares | low |
| Mar 2, 2026 | Gheuens Sarah Executive | Exercise | Restricted stock units | — | -6K -50.00% | 5,667 <0.01% of shares | low |
| Mar 2, 2026 | Gheuens Sarah Executive | Exercise | Restricted stock units | — | -4K -100.00% | 0 0.00% of shares | low |
| Mar 1, 2026 | Gheuens Sarah Executive | Grant | Stock options (right to buy) | — | +52K | 52,000 0.09% of shares | low |
| Mar 1, 2026 | Gheuens Sarah Executive | Grant | Restricted stock units | — | +22K | 22,000 0.04% of shares | low |
| Mar 1, 2026 | Gheuens Sarah Executive | Grant | Restricted stock units | — | +14K | 14,000 0.02% of shares | low |
| Mar 2, 2026 | Milanova Tsveta Executive | Exercise | Restricted stock units | — | -4K -33.33% | 8,000 0.01% of shares | low |
| Mar 2, 2026 | Milanova Tsveta Executive | Exercise | Restricted stock units | — | -6K -50.00% | 5,667 <0.01% of shares | low |
| Mar 1, 2026 | Milanova Tsveta Executive | Grant | Stock options (right to buy) | — | +52K | 52,000 0.09% of shares | low |
| Mar 1, 2026 | Milanova Tsveta Executive | Grant | Restricted stock units | — | +14K | 14,000 0.02% of shares | low |
| Mar 2, 2026 | Washburn Theodore James Jr. Executive | Exercise | Restricted stock units | — | -3K -33.33% | 5,390 <0.01% of shares | low |
| Mar 2, 2026 | Washburn Theodore James Jr. Executive | Exercise | Restricted stock units | — | -2K -50.00% | 2,450 <0.01% of shares | low |
| Mar 2, 2026 | Washburn Theodore James Jr. Executive | Exercise | Restricted stock units | — | -2K -100.00% | 0 0.00% of shares | low |
| Mar 1, 2026 | Washburn Theodore James Jr. Executive | Grant | Restricted stock units | — | +8K | 8,452 0.01% of shares | low |